We are live on
!
Find out more
Federated Hermes Portfolio holdings
AUM
$69.6B
1-Year Est. Return
42.52%
This Fund
S&P 500
This Quarter
Est. Return
+13.69%
1 Year Est. Return
+42.52%
3 Year Est. Return
+132.48%
5 Year Est. Return
+152.58%
10 Year Est. Return
+652.43%
AUM
$53.1B
AUM Growth
+$6.76B
(+15%)
Cap. Flow
+$2.33B
Cap. Flow
% of AUM
4.39%
Top 10 Holdings %
Top 10 Hldgs %
14.65%
Holding
2,220
New
169
Increased
729
Reduced
1,033
Closed
165
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Zscaler
ZS
|
+$222M |
| 2 |
Palantir
PLTR
|
+$221M |
| 3 |
Alphabet (Google) Class A
GOOGL
|
+$213M |
| 4 |
FirstEnergy
FE
|
+$189M |
| 5 |
Broadcom
AVGO
|
+$174M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Bristol-Myers Squibb
BMY
|
+$383M |
| 2 |
Philip Morris
PM
|
+$280M |
| 3 |
Entergy
ETR
|
+$207M |
| 4 |
Paychex
PAYX
|
+$206M |
| 5 |
Gilead Sciences
GILD
|
+$201M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 22.81% |
| 2 | Healthcare | 14.57% |
| 3 | Financials | 13.43% |
| 4 | Industrials | 10.29% |
| 5 | Consumer Discretionary | 9.94% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
BIOA
1901
BioAge Labs
BIOA
$463M
| $4.12K | ﹤0.01% |
+998
| New | +$4.02K |
|
1902
SmartFinancial
SMBK
$865M
| $4.12K | ﹤0.01% |
+122
| New | +$3.77K |
|
1903
Bloomin' Brands
BLMN
$894M
| $4.09K | ﹤0.01% |
475
-712
| -60% | -$5.72K |
|
1904
Arlo Technologies
ARLO
$1.41B
| $4.09K | ﹤0.01% |
241
-88
| -27% | -$1.13K |
|
|
PENG
1905
Penguin Solutions Inc
PENG
$2.69B
| $4.08K | ﹤0.01% |
206
-1,137
| -85% | -$20.6K |
|
1906
M-tron Industries
MPTI
$340M
| $4.07K | ﹤0.01% |
97
-110
| -53% | -$5.3K |
|
1907
Kulicke & Soffa
KLIC
$4.43B
| $3.98K | ﹤0.01% |
115
-1,264
| -92% | -$41.1K |
|
|
PPLI
1908
People Inc
PPLI
$2.93B
| $3.92K | ﹤0.01% |
105
-23
| -18% | -$831 |
|
1909
Carriage Services
CSV
$544M
| $3.8K | ﹤0.01% |
83
-103
| -55% | -$4.3K |
|
1910
Honda
HMC
$40.7B
| $3.78K | ﹤0.01% |
131
| – | – |
|
|
CBL
1911
CBL Properties
CBL
$1.7B
| $3.76K | ﹤0.01% |
148
+96
| +185% | +$2.37K |
|
1912
Team
TISI
$110M
| $3.71K | ﹤0.01% |
204
| – | – |
|
1913
Investar Holding Corp
ISTR
$417M
| $3.71K | ﹤0.01% |
192
-31
| -14% | -$572 |
|
1914
Q32 Bio
QTTB
$481M
| $3.65K | ﹤0.01% |
2,452
-30
| -1% | -$51 |
|
1915
iRadimed
IRMD
$1.11B
| $3.65K | ﹤0.01% |
61
| – | – |
|
1916
Wave Life Sciences
WVE
$1.02B
| $3.6K | ﹤0.01% |
553
-55,305
| -99% | -$365K |
|
1917
PACS Group
PACS
$7B
| $3.48K | ﹤0.01% |
269
-40
| -13% | -$416 |
|
1918
CuriosityStream
CURI
$152M
| $3.29K | ﹤0.01% |
585
| – | – |
|
1919
Univest Financial
UVSP
$1.15B
| $3.24K | ﹤0.01% |
108
+20
| +23% | +$582 |
|
1920
Groupon
GRPN
$792M
| $3.18K | ﹤0.01% |
95
+15
| +19% | +$383 |
|
1921
TScan Therapeutics
TCRX
$50.8M
| $3.16K | ﹤0.01% |
2,181
-1
| -0% | -$1 |
|
1922
Barclays
BCS
$90.3B
| $3.12K | ﹤0.01% |
168
-58
| -26% | -$959 |
|
1923
Outset Medical
OM
$76.9M
| $3.11K | ﹤0.01% |
+162
| New | +$2.53K |
|
1924
Mitek Systems
MITK
$867M
| $3.11K | ﹤0.01% |
+314
| New | +$2.82K |
|
1925
Zurn Elkay Water Solutions
ZWS
$8.05B
| $3.11K | ﹤0.01% |
85
-1,695
| -95% | -$58.3K |
|
Similar funds
Federated Hermes's Q2 2025 Portfolio in Review
As of Q2 2025, Federated Hermes held 2,220 positions worth $53.1B, up 15% from $46.4B the previous quarter. Its ten largest holdings account for 15% of the portfolio.
Federated Hermes deployed $2.33B of net new capital in Q2 2025, opening 169 new positions and adding to 729 existing holdings. Its largest new stake was Genuine Parts: 882,160 shares worth $107M.
By sector, the portfolio is most concentrated in Technology at 23% of assets, up from 20% a quarter earlier, followed by Healthcare and Financials.
On the sell side, the largest reduction was Bristol-Myers Squibb, an estimated $383M trimmed.
- Federated Hermes's largest Q2 2025 buy was Genuine Parts: 882,160 shares worth $107M.
- Federated Hermes added most to Zscaler in Q2 2025, an estimated $222M increase.
- Federated Hermes's biggest Q2 2025 reduction was Bristol-Myers Squibb, cutting an estimated $383M.
- Federated Hermes fully exited Regulus Therapeutics in Q2 2025, selling an estimated $39.2M.
- Federated Hermes's ten largest holdings make up 15% of its $53.1B portfolio in Q2 2025.
- Federated Hermes opened 169 new positions and closed 165 in Q2 2025.
- Federated Hermes's portfolio value rose 15% quarter-over-quarter to $53.1B.
Based on Federated Hermes's 13F filing for Q2 2025, filed 13 Aug 2025.